Moxifloxacin vs Nivolumab

## Moxifloxacin vs Nivolumab: Overview

This comparison examines the pharmacological differences between **Moxifloxacin** and **Nivolumab**.

## Mechanism of Action

**Moxifloxacin**: Fourth-generation fluoroquinolone inhibiting DNA gyrase and topoisomerase IV with enhanced anaerobic activity.

**Nivolumab**: Fully human anti-PD-1 IgG4 monoclonal antibody restoring T-cell anti-tumor activity.

## Pharmacokinetics

**Half-life**: Moxifloxacin — 12 hours; Nivolumab — 27 days.

## Chemical Properties

**Molecular Formula**: Moxifloxacin — C21H24FN3O4; Nivolumab — N/A.

**Molecular Weight**: Moxifloxacin — 401.4350 g/mol; Nivolumab — N/A.

**Type**: Moxifloxacin — Small molecule; Nivolumab — Antibody.